Xtx Topco LTD Rigel Pharmaceuticals Inc Transaction History

Xtx Topco LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$1.12 - $1.57 $289,952 - $406,451	258,886 Added 464.96%	314,565 $465,000
Q4 2023 Feb 13, 2024	SELL	$0.72 - $1.56 $78,162 - $169,352	-108,559 Reduced 66.1%	55,679 $80,000
Q3 2023 Nov 13, 2023	BUY	$1.07 - $1.39 $115,327 - $149,818	107,783 Added 190.92%	164,238 $177,000
Q2 2023 Aug 14, 2023	SELL	$1.12 - $1.82 $291,575 - $473,809	-260,335 Reduced 82.18%	56,455 $72,000
Q1 2023 May 12, 2023	BUY	$1.25 - $2.0 $369,855 - $591,768	295,884 Added 1415.31%	316,790 $418,000
Q4 2022 Feb 14, 2023	SELL	$0.67 - $11.9 $283,954 - $5.04 Million	-423,813 Reduced 95.3%	20,906 $31,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $12.2 $332,785 - $3.69 Million	302,532 Added 212.77%	444,719 $525,000
Q2 2022 Aug 15, 2022	BUY	$0.67 - $3.19 $88,433 - $421,051	131,991 Added 1294.54%	142,187 $161,000
Q1 2022 May 13, 2022	SELL	$2.22 - $3.45 $73,393 - $114,057	-33,060 Reduced 76.43%	10,196 $30,000
Q4 2021 Feb 11, 2022	BUY	$2.36 - $3.57 $102,084 - $154,423	43,256 New	43,256 $115,000
Q3 2021 Nov 12, 2021	SELL	$3.5 - $4.5 $129,073 - $165,951	-36,878 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.09 - $4.54 $113,953 - $167,426	36,878 New	36,878 $160,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.